KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $325,000 | +66.7% | 59,480 | +124.6% | 0.00% | 0.0% |
| Q1 2022 | $195,000 | +5.4% | 26,482 | -8.0% | 0.00% | – |
| Q4 2021 | $185,000 | +12.1% | 28,798 | +1.4% | 0.00% | – |
| Q3 2021 | $165,000 | -43.5% | 28,400 | +0.4% | 0.00% | -100.0% |
| Q2 2021 | $292,000 | +5.8% | 28,300 | +49.7% | 0.00% | -50.0% |
| Q3 2020 | $276,000 | -70.1% | 18,900 | -60.6% | 0.00% | -71.4% |
| Q1 2020 | $922,000 | -8.6% | 48,000 | -8.8% | 0.01% | 0.0% |
| Q4 2019 | $1,009,000 | – | 52,616 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |